Business Wire

New Research Shows Consumers Pay the Price of Policy Abuse Epidemic As Retailers Worldwide Tighten Return and Refund Policies

Share

Riskified (NYSE:RSKD), a leader in ecommerce fraud and risk intelligence, today published its “Returns, refunds & exchanges: Global insights and policy playbook 2024,” a thorough examination of returns and refunds operations at ecommerce enterprises worldwide and the impact of fraud and abuse on retailer policies. The study of seven major markets, including US, UK, France, DACH, Mexico, Brazil, and Australia / New Zealand, uncovered that returns, refunds, and exchanges constitute a staggering $394 billion expense for retailers, at least $28 billion of which is perceived to be impacted by fraud and abuse.

Policy abuse, in which consumers knowingly exploit or manipulate a merchant’s terms and conditions for personal gain, includes behaviors such as ordering multiple sizes and colors with the intent to return most items (“bracketing”), claiming “item not received” (INR) or “did not arrive” (DNR), returning an item as if unworn for full refund (“wardrobing”), and more.

Not only are regular consumers committing abuse, professional fraudsters are magnifying the challenge. Driven by information-sharing forums like “fraud-as-a-service" groups on the Dark Web and the availability of malicious generative artificial intelligence (GenAI) tools, fraud and abuse have become more prolific and sophisticated. Because of this, three in four online merchants say they feel overwhelmed by policy abuse, while 84% find it harder to detect abuse of their returns and refund policies.

Now, Riskified’s research reveals that many merchants are tightening up returns and refunds policies due to mounting costs and the high risk of fraud and policy abuse, a reversal from the generous and flexible policies online shoppers have come to expect and appreciate from their favorite retailers.

  • One-third of retailers now charge a fee for returning an item.
  • One-third of retailers are issuing exchange-only and store credit-only policies.
  • Two in five online retailers now allow just seven days to file a claim. In contrast, brick-and-mortar stores have historically provided 30 days for returns, refunds, and exchanges.

Most merchants aren’t proactively tackling policy abuse, with only three of 10 merchants saying they have implemented a strategy to prevent fraudulent returns and refunds. Internal challenges contribute to this situation, such as lack of data integration between teams (26%), competing objectives between teams (25%), and lack of collaboration in general (24%). To alleviate this problem, merchants can adopt strategies such as a “sliding scale” return and refund policies based on customer value, using an identity-based technology approach to identify bad actors, or even banning serial refund and returns customers entirely.

“The pendulum has swung from generous return and refund policies of previous years to increasingly restrictive policies,” said Jeff Otto, CMO at Riskified. “Merchants are under pressure to cut costs, but if this correction is applied bluntly across all customers it creates a bad experience for high-value shoppers, stunting growth and loyalty. The good news is this problem can be addressed surgically with an identity-based technology approach that carefully assesses the right policy to implement across the spectrum of customers – maintaining generous policies to delight high-value customers, while cutting-off abusive identities at the point of purchase or claim.”

To produce this report, Riskified commissioned Opinium Research to interview over 500 senior directors with oversight of fraud, risk, and policy abuse at large ecommerce businesses spanning North and South America, Europe, and Australasia. In addition, the Center for Economics and Business Research (Cebr) layered economic modeling data and analysis to determine the direct and indirect costs of fraud and policy abuse on returns, refunds, and exchanges.Download “Returns, refunds & exchanges: Global insights and policy playbook 2024” via Riskified.com.

About Riskified

Riskified (NYSE:RSKD) empowers businesses to unleash ecommerce growth by outsmarting risk. Many of the world’s biggest brands and publicly traded companies selling online rely on Riskified for guaranteed protection against chargebacks, to fight fraud and policy abuse at scale, and to improve customer retention. Developed and managed by the largest team of ecommerce risk analysts, data scientists and researchers, Riskified’s AI-powered fraud and risk intelligence platform analyzes the individual behind each interaction to provide real-time decisions and robust identity-based insights. Riskified was named to CNBC's World’s Top Fintech Companies in 2024. Learn more at riskified.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241009450520/en/

Contacts

Cristina Dinozo
Sr. Director of Communications
press@riskified.com

Chett Mandel
Head of Investor Relations
ir@riskified.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Volante Technologies Customers Successfully Navigate Critical Regulatory Deadlines for EU SEPA Instant and Global SWIFT Cross-Border Payments16.12.2025 10:00:00 CET | Press Release

Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European milestone, requiring payments to be made within 10 seconds and at any time of day, throughout the year. Adoption was mandatory and Eurozone banks were compelled to meet strict deadlines, with January 9th, 2025 the deadline for receiving incoming instant payments and October 9th the deadline for sending outgoing instant payments. The latest deadline impacted more than 700 banks across Europe, with non-compliance penalties reaching at least 10% of annual net turnover. SWIFT SRG 2025 is another seismic update, representing the

TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press Release

TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver

RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge ® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press Release

Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support commercial manufacturing of Omisirge® for this additional indication at its state-of-the-art cGMP cell therapy manufacturing facility in Hopkinton, MA. “We are excited to expand our collaboration with RoslinCT to add US manufacturing as Omisirge® moves into its next phase with the recent FDA approval for patients suffering from severe apl

Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press Release

Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It proves a supplier has undergone an exhaustive audit of its governance, security controls, and operational processes. For Dutch financial institutions, this qualificatio

Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press Release

Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye